Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Raju Sunagar

Showing results (1-10 of 19) with videos related to

Pageof 2
Sort By:
Vaccines|April 28, 2023
SARS-CoV-2: Immunity, Challenges with Current Vaccines, and a Novel Perspective on Mucosal VaccinesRaju Sunagar, Amit Singh, Sudeep Kumar
Frontiers in Immunology|June 14, 2019
Bacterial Protein Toll-Like-Receptor Agonists: A Novel Perspective on Vaccine AdjuvantsSudeep Kumar, Raju Sunagar, Edmund Gosselin
Vaccines|April 29, 2020
Preclinical Efficacy of a Trivalent Human FcγRI-Targeted Adjuvant-Free Subunit Mucosal Vaccine against Pulmonary Pneumococcal InfectionSudeep Kumar, Raju Sunagar, Edmund J Gosselin
Research in Microbiology|September 28, 2010
Bacteriophage therapy for Staphylococcus aureus bacteremia in streptozotocin-induced diabetic miceRaju Sunagar, Shripad A Patil, R Kelmani Chandrakanth
Frontiers in Immunology|December 26, 2022
Preclinical evaluation of safety and immunogenicity of a primary series intranasal COVID-19 vaccine candidate (BBV154) and humoral immunogenicity evaluation of a heterologous prime-boost strategy with COVAXIN (BBV152)Raju Sunagar, Sai D Prasad, Raches Ella, et al.
Vaccine|May 17, 2016
Vaccination evokes gender-dependent protection against tularemia infection in C57BL/6Tac miceRaju Sunagar, Sudeep Kumar, Brian J Franz, et al.
Vaccine (Auckland, N.Z.)|May 21, 2016
Tularemia vaccine development: paralysis or progress?Raju Sunagar, Sudeep Kumar, Brian J Franz, et al.
Vaccine|January 11, 2017
Ex vivo antigen-pulsed PBMCs generate potent and long lasting immunity to infection when administered as a vaccineSudeep Kumar, Raju Sunagar, Giang Pham, et al.
Journal of Basic Microbiology|May 21, 2013
Human methicillin-sensitive Staphylococcus aureus biofilms: potential associations with antibiotic resistance persistence and surface polysaccharide antigensCharlene Babra, Jully Tiwari, Paul Costantino, et al.
Frontiers in Immunology|July 26, 2018
Differential <i>In Vitro</i> Cultivation of <i>Francisella tularensis</i> Influences Live Vaccine Protective Efficacy by Altering the Immune ResponseRaju Sunagar, Sudeep Kumar, Sarah J Rosa, et al.
Pageof 2

Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
Vaccines|April 28, 2023
SARS-CoV-2: Immunity, Challenges with Current Vaccines, and a Novel Perspective on Mucosal VaccinesRaju Sunagar, Amit Singh, Sudeep Kumar
Frontiers in Immunology|June 14, 2019
Bacterial Protein Toll-Like-Receptor Agonists: A Novel Perspective on Vaccine AdjuvantsSudeep Kumar, Raju Sunagar, Edmund Gosselin
Vaccines|April 29, 2020
Preclinical Efficacy of a Trivalent Human FcγRI-Targeted Adjuvant-Free Subunit Mucosal Vaccine against Pulmonary Pneumococcal InfectionSudeep Kumar, Raju Sunagar, Edmund J Gosselin
Research in Microbiology|September 28, 2010
Bacteriophage therapy for Staphylococcus aureus bacteremia in streptozotocin-induced diabetic miceRaju Sunagar, Shripad A Patil, R Kelmani Chandrakanth
Frontiers in Immunology|December 26, 2022
Preclinical evaluation of safety and immunogenicity of a primary series intranasal COVID-19 vaccine candidate (BBV154) and humoral immunogenicity evaluation of a heterologous prime-boost strategy with COVAXIN (BBV152)Raju Sunagar, Sai D Prasad, Raches Ella, et al.
Vaccine|May 17, 2016
Vaccination evokes gender-dependent protection against tularemia infection in C57BL/6Tac miceRaju Sunagar, Sudeep Kumar, Brian J Franz, et al.
Vaccine (Auckland, N.Z.)|May 21, 2016
Tularemia vaccine development: paralysis or progress?Raju Sunagar, Sudeep Kumar, Brian J Franz, et al.
Vaccine|January 11, 2017
Ex vivo antigen-pulsed PBMCs generate potent and long lasting immunity to infection when administered as a vaccineSudeep Kumar, Raju Sunagar, Giang Pham, et al.
Journal of Basic Microbiology|May 21, 2013
Human methicillin-sensitive Staphylococcus aureus biofilms: potential associations with antibiotic resistance persistence and surface polysaccharide antigensCharlene Babra, Jully Tiwari, Paul Costantino, et al.
Frontiers in Immunology|July 26, 2018
Differential <i>In Vitro</i> Cultivation of <i>Francisella tularensis</i> Influences Live Vaccine Protective Efficacy by Altering the Immune ResponseRaju Sunagar, Sudeep Kumar, Sarah J Rosa, et al.
Pageof 2